Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-02-21 @ 10:59 PM
Study NCT ID:
NCT00436605
Status:
COMPLETED
Last Update Posted:
2014-05-15
First Post:
2007-02-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-15
First Submit QC Date:
None
Study First Post Date:
2007-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-12-05
Results First Submit QC Date:
None
Results First Post Date:
2014-01-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-29
Last Update Post Date:
2014-05-15
Last Update Post Date Type:
ESTIMATED